426 related articles for article (PubMed ID: 31169019)
1. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
Tao L; Wu YQ; Zhang SP
Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
[TBL] [Abstract][Full Text] [Related]
2. miR-145-5p attenuates paclitaxel resistance and suppresses the progression in drug-resistant breast cancer cell lines.
Guan X; Guan Y
Neoplasma; 2020 Sep; 67(5):972-981. PubMed ID: 32412771
[TBL] [Abstract][Full Text] [Related]
3. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
Zang H; Li Y; Zhang X; Huang G
Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
[TBL] [Abstract][Full Text] [Related]
4. Circ_0,007,331 Promotes the PTX Resistance and Progression of Breast Cancer via miR-200b-3p/ANLN.
Yang C; Liu L; Gao C; Zhang G; Zhang Y; Zhang S; Li J; Liu Y
J Surg Res; 2022 Nov; 279():619-632. PubMed ID: 35926312
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
[TBL] [Abstract][Full Text] [Related]
6. CircMKLN1 Suppresses the Progression of Human Retinoblastoma by Modulation of miR-425-5p/PDCD4 Axis.
Xu L; Long H; Zhou B; Jiang H; Cai M
Curr Eye Res; 2021 Nov; 46(11):1751-1761. PubMed ID: 33988065
[No Abstract] [Full Text] [Related]
7. MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel.
Rasoolnezhad M; Safaralizadeh R; Hosseinpour Feizi MA; Banan-Khojasteh SM; Roshani Asl E; Lotfinejad P; Baradaran B
Mol Biol Rep; 2023 Oct; 50(10):8407-8420. PubMed ID: 37620737
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis.
Zhang R; Xia T
Int J Oncol; 2017 Nov; 51(5):1460-1470. PubMed ID: 29048648
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19.
Zheng P; Dong L; Zhang B; Dai J; Zhang Y; Wang Y; Qin S
Histochem Cell Biol; 2019 Oct; 152(4):281-291. PubMed ID: 31352515
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy.
Zheng S; Fu W; Huang Q; Zhou J; Lu K; Gu J; Ma R; Guo G
Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):431-442. PubMed ID: 36732923
[TBL] [Abstract][Full Text] [Related]
11. Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR-136-5p/YWHAZ axis.
Kong Z; Han Q; Zhu B; Wan L; Feng E
Thorac Cancer; 2023 Jul; 14(19):1831-1842. PubMed ID: 37192740
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y
Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting the PDCD4.
Cheng Y; Xiang G; Meng Y; Dong R
Reprod Biol; 2016 Sep; 16(3):225-233. PubMed ID: 27476679
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of SNHG12 accelerates cell proliferation, migration, invasion and restrain cell apoptosis in breast cancer by enhancing regulating SALL4 expression via sponging miR-15a-5p.
Yuan JH; Li WX; Hu C; Zhang B
Neoplasma; 2020 Jul; 67(4):861-870. PubMed ID: 32386479
[TBL] [Abstract][Full Text] [Related]
15. LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer.
Jiang Z; Li L; Hou Z; Liu W; Wang H; Zhou T; Li Y; Chen S
Cell Signal; 2020 Feb; 66():109483. PubMed ID: 31760170
[TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_0008259 modulates miR-21-5p and PDCD4 expression to restrain osteosarcoma progression.
Guan K; Liu S; Duan K; Zhang X; Liu H; Xu B; Wang X; Jin X
Aging (Albany NY); 2021 Dec; 13(23):25484-25495. PubMed ID: 34905503
[TBL] [Abstract][Full Text] [Related]
17. Circ_0003266 sponges miR-503-5p to suppress colorectal cancer progression via regulating PDCD4 expression.
Wen C; Feng X; Yuan H; Gong Y; Wang G
BMC Cancer; 2021 Mar; 21(1):284. PubMed ID: 33726686
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
[TBL] [Abstract][Full Text] [Related]
19. Exosomal circDNER enhances paclitaxel resistance and tumorigenicity of lung cancer via targeting miR-139-5p/ITGB8.
Li J; Zhu T; Weng Y; Cheng F; Sun Q; Yang K; Su Z; Ma H
Thorac Cancer; 2022 May; 13(9):1381-1390. PubMed ID: 35396925
[TBL] [Abstract][Full Text] [Related]
20. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
